"Trinity Tony Teramana Medical Oncology is a Cancer Treatment Center located in Steubenville.Visit our website to learn more about the conditions we treat and the services we offer. Schedule your appointment today. UPMC is committed to protecting our communities from the spread of COVID-19. We continue to require people who come to any UPMC facility to wear a facemask that covers their nose and mouth and to practice other preventative efforts like social distancing, even if fully vaccinated."

During the past decade, Trinity's Tony Teramana Cancer Center conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 16 clinical trials were completed, i.e. on average, 72.7% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 10 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Trinity's Tony Teramana Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 17 trials, followed by "Alliance for Clinical Trials in Oncology" with 6 trials sponsored, "SWOG Cancer Research Network" with 6 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 3 trials sponsored and "University of Pittsburgh" with 3 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Trinity's Tony Teramana Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 17 trials as a collaborator, "Canadian Cancer Trials Group" with 3 trials as a collaborator, "NRG Oncology" with 2 trials as a collaborator, "Amgen" with 1 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Trinity's Tony Teramana Cancer Center" are "Invasive Breast Carcinoma" (4 trials), "Recurrent Breast Carcinoma" (3 trials), "Recurrent Squamous Cell Lung Carcinoma" (3 trials), "Stage IIIB Lung Cancer AJCC v8" (3 trials) and "Anatomic Stage II Breast Cancer AJCC v8" (2 trials). Many other conditions were trialed in "Trinity's Tony Teramana Cancer Center" in a lesser frequency.

Most popular intervention types in "Trinity's Tony Teramana Cancer Center" are "Drug" (33 trials), "Other" (24 trials), "Biological" (15 trials), "Procedure" (8 trials) and "Radiation" (4 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (12 trials), "Quality-of-Life Assessment" (10 trials), "Carboplatin" (7 trials), "Paclitaxel" (7 trials) and "Questionnaire Administration" (7 trials). Other intervention names were less common.

The vast majority of trials in "Trinity's Tony Teramana Cancer Center" are 32 trials for "All" genders, 4 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Trinity's Tony Teramana Cancer Center". undefined are not yet recruiting, 11 are recruiting, 17 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Trinity's Tony Teramana Cancer Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Trinity's Tony Teramana Cancer Center, 0 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".